Wedge Capital Management L L P Ultragenyx Pharmaceutical Inc. Transaction History
Wedge Capital Management L L P
- $5.04 Billion
- Q1 2025
A detailed history of Wedge Capital Management L L P transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 35,695 shares of RARE stock, worth $1.39 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
35,695Holding current value
$1.39 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
341Shares Held
84.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$218 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$168 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$106 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.9 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.73B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...